Related Experiment Video
Updated: Dec 31, 2025
2D and 3D Matrices to Study Linear Invadosome Formation and Activity
Published on: June 2, 2017
Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion
1Division of Cancer Cell Research, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan. mseiki@ims.u-tokyo.ac.jp
Abstract:
Matrix metalloproteinases (MMPs) are believed to play a pivotal role in malignant behavior of cancer cells such as rapid tumor growth, invasion, and metastasis by degrading extracellular matrix (ECM). Different types of synthetic inhibitors against MMPs (MMPIs) were developed as candidates for anti-cancer therapeutics and so far clinical trials had led to no significant success. However, this does not diminish the importance of MMPs in the malignancy of cells. Details about MMPs, specifically when and how they take part in the development of cancer are necessary for more advanced application of MMPIs. In this paper, we summarize recent knowledge about membrane-type 1 matrix metalloproteinase (MT1-MMP) which is expressed on cancer cell surface as an invasion-promoting proteinase. By localizing at the leading edge of invasive cancer cells, MT1-MMP degrades components of the tissue barriers. One of the major targets is type I collagen, the most abundant ECM component. Although MT1-MMP itself cannot degrade type IV collagen in the basement membrane, it binds to and activates proMMP-2, one of the type IV collagenases. However, degradation of the ECM is not the sole function of MT1-MMP. MT1-MMP also regulates cell-ECM interaction by processing cell adhesion molecules such as CD44 and integrin alphav chain, and eventually promotes cell migration as well. In addition to the transcriptional regulation, invasion-promoting activity of the MT1-MMP is also strictly monitored at the post-translational level. Precise knowledge about the regulation will give us insight to develop new methods for treating invasive cancer patients.
Insights
Matrix metalloproteinases (MMPs) are crucial for cancer invasion and metastasis. Membrane-type 1 MMP (MT1-MMP) degrades extracellular matrix and promotes cancer cell migration, offering therapeutic targets.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- Matrix metalloproteinases (MMPs) facilitate cancer cell invasion and metastasis by degrading the extracellular matrix (ECM).
- Synthetic MMP inhibitors (MMPIs) have shown limited success in clinical trials for cancer therapy.
- Understanding MMP roles in cancer progression is vital for developing effective anti-cancer strategies.
Purpose of the Study:
- To review current knowledge on membrane-type 1 matrix metalloproteinase (MT1-MMP) and its role in cancer.
- To elucidate MT1-MMP's mechanisms in promoting cancer cell invasion and metastasis.
- To highlight the importance of MT1-MMP regulation for future therapeutic development.
Main Methods:
- Literature review of studies on MT1-MMP function and regulation in cancer.
- Analysis of MT1-MMP's interactions with ECM components and cell adhesion molecules.
- Examination of MT1-MMP's post-translational regulation and its impact on cancer malignancy.
Main Results:
- MT1-MMP is a cell-surface proteinase crucial for cancer invasion, degrading ECM components like type I collagen.
- MT1-MMP activates proMMP-2, aiding basement membrane degradation, and modulates cell-ECM interactions by processing CD44 and integrins.
- MT1-MMP activity is regulated at both transcriptional and post-translational levels, influencing cancer cell migration and invasion.
Conclusions:
- MT1-MMP is a key mediator of cancer cell invasion and metastasis through ECM degradation and modulation of cell adhesion.
- Understanding the precise regulation of MT1-MMP offers potential for novel therapeutic strategies against invasive cancers.
- Targeting MT1-MMP and its regulatory pathways may overcome limitations of previous MMPIs and improve cancer treatment outcomes.
Related Concept Videos
01:23Role of Matrix Metalloproteases in Degradation of ECM
01:35Cancer Cell Migration through Invadopodia
02:17The Tumor Microenvironment
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:29The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
01:42The Extracellular Matrix